| Physiology, renal I Ogobuiro, F Tuma | 69 | 2019 |
| Physiology, gastrointestinal I Ogobuiro, J Gonzales, KR Shumway, F Tuma StatPearls [Internet], 2023 | 50 | 2023 |
| Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer A Bianchi, I De Castro Silva, NU Deshpande, S Singh, S Mehra, ... Cancer discovery 13 (6), 1428-1453, 2023 | 25 | 2023 |
| Anatomy, thorax, heart coronary arteries I Ogobuiro, CJ Wehrle, F Tuma | 24 | 2018 |
| Physiology, Renal.[Updated 2021 Jul 26] I Ogobuiro, F Tuma StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2021 | 9 | 2021 |
| StatPearls I Ogobuiro, F Tuma StatPearls, 2022 | 6 | 2022 |
| Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer I Ogobuiro, Y Baca, JR Ribeiro, P Walker, GC Wilson, P Gulhati, ... JCO precision oncology 7, e2300152, 2023 | 5 | 2023 |
| Physiology, Gastrointestinal.[Updated 2021 Apr 25] I Ogobuiro, G Justin, T Faiz StatPearls [Internet], 0 | 5 | |
| Racial disparity in pathologic response following neoadjuvant chemotherapy in resected pancreatic cancer: a multi-institutional analysis from the Central Pancreatic Consortium I Ogobuiro, AL Collier, K Khan, I de Castro Silva, D Kwon, GC Wilson, ... Annals of surgical oncology 30 (3), 1485-1494, 2023 | 4 | 2023 |
| Everything old is new again. revisiting hypophysectomy for the treatment of refractory cancer-related pain: a systematic review T Almeida, BA Monaco, F Vasconcelos, GS Piedade, A Morell, I Ogobuiro, ... Neurosurgical Review 47 (1), 1-9, 2024 | 1 | 2024 |
| Rural melanoma patients have less surgery and higher melanoma-specific mortality AE Hernandez, KN Benck, CT Huerta, I Ogobuiro, G De La Cruz Ku, ... The American Surgeon™ 90 (4), 510-517, 2024 | 1 | 2024 |
| Racial and ethnic minorities in lower income brackets are associated with late-stage diagnosis of non-ocular melanoma P Joshi, I Ogobuiro, A Hernandez, GDLC Ku, DG Noe, L Feun, ZJ Liu, ... Cancer Epidemiology 87, 102489, 2023 | 1 | 2023 |
| Black Race and CA 19-9 Nonproduction is Associated with Limited Pathologic Response to Neoadjuvant Chemotherapy in Patients with Localized Pancreatic Cancer MP Martos, EM Dickey, UR Yanala, K Abdilleh, I Ogobuiro, EW Box, ... ANNALS OF SURGICAL ONCOLOGY 31 (1), S167-S168, 2024 | | 2024 |
| Disrupting TNFR2 Signaling Improves Chemotherapy sensitivity in Pancreatic Cancer H Amirian, Bianc-, Anna, I, K Rajkumar, A-am, Andrew, IDC Silva, ... ANNALS OF SURGICAL ONCOLOGY 31 (1), S29-S29, 2024 | | 2024 |
| A novel mechanism of immunotherapy sensitivity following platinum chemotherapy resistance in pancreatic cancer patients with germline homologous recombination deficiency I Ogobuiro, K Rajkumar, A Bianchi, L Caeiro, H Amirian, L Nivelo, ... ANNALS OF SURGICAL ONCOLOGY 31 (1), S24-S25, 2024 | | 2024 |
| KRAS mutation status in the prediction of pancreatic tumor response after neoadjuvant systemic therapy and magnetic resonance-guided SBRT. A Jethanandani, NA Hanson, I Ogobuiro, G Simpson, C Montoya, ... Journal of Clinical Oncology 42 (3_suppl), 709-709, 2024 | | 2024 |
| Association of race and CA 19-9 nonproduction with limited pathologic response to neoadjuvant chemotherapy in patients with localized pancreatic cancer. MP Martos, EM Dickey, UR Yanala, K Abdilleh, I Ogobuiro, EW Box, ... Journal of Clinical Oncology 42 (3_suppl), 609-609, 2024 | | 2024 |
| Abstract C064: Chronic platinum exposure induces cell-intrinsic type1 interferon/STING pathway activation in homologous recombination-deficient pancreatic cancer to drive … I Ogobuiro, A Bianchi, L Caeiro, H Amirian, L Nivelo, I De Castro Silva, ... Cancer Research 84 (2_Supplement), C064-C064, 2024 | | 2024 |
| Abstract C021: Granulocytic MDSC-derived NLRP3 inflammasome activation is a novel regulator of inflammatory CAF skewness in pancreatic cancer K Rajkumar, NU Deshpande, I de Castro Silva, A Bianchi, I Ogobuiro, ... Cancer Research 84 (2_Supplement), C021-C021, 2024 | | 2024 |
| Abstract PR16: Neutrophil-intrinsic tumor necrosis factor (TNF) is a novel driver of T-cell and cancer-associated fibroblast (CAF) dysfunction in pancreatic cancer A Bianchi, H Amirian, I De Castro Silva, I Ogobuiro, K Rajkumar, ... Cancer Research 84 (2_Supplement), PR16-PR16, 2024 | | 2024 |
